![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 29, 20110-20115, July 16, 1999
From the Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
| |
ABSTRACT |
|---|
|
|
|---|
Proteins of the Hsp70 family of ATPases interact
with a conserved domain of their J-protein partners, the J-domain, to
function in numerous cellular processes. We have studied the
interaction of BiP, an Hsp70 family member in the lumen of the
endoplasmic reticulum, with the J-domain of Sec63p, a component of the
Sec complex involved in post-translational protein translocation across the endoplasmic reticulum membrane. In a real-time solid phase binding
assay, BiP binds to the immobilized Sec complex or to a fusion protein
of the J-domain and glutathione S-transferase in a reaction
that requires ATP hydrolysis. In the final complex, BiP is bound in the
ADP form with its peptide binding pocket occupied. An intact peptide
binding pocket is required for this interaction. Our experiments
suggest that the activation of BiP by the J-domain involves a transient
contact between these components, and that in the absence of
physiological substrates, J-activated BiP binds even to the J-proteins themselves.
Hsp70s exist in most cellular compartments. They participate in
many different processes, including protein folding, assembly and
disassembly of protein complexes, uncoating of clathrin-coated vesicles, and transport of proteins across membranes (for review, see
Refs. 1-4). Hsp70s are able to perform these apparently different tasks because of their ability to reversibly bind polypeptides. Hsp70s
bind peptides through a peptide binding pocket which is regulated by
the NH2-terminal ATPase domain (for review, see Ref. 4).
With ATP bound to the ATPase domain, the peptide binding pocket is open
and peptides can rapidly bind and dissociate. In the presence of ADP,
the pocket is closed and covered by a lid domain (5), and association
and dissociation of peptides are much slower (6, 7).
To bind substrates under physiological conditions Hsp70s cooperate with
their co-factors, the J-proteins (for review, see Ref. 8). J-proteins
are a ubiquitous family defined by a conserved domain of about 70 amino
acids, the J-domain. In addition, they contain other, nonconserved
domains which are responsible for association of the J-proteins with
different polypeptide substrates. It is believed that the J-domain
interacts with Hsp70 molecules and stimulates their ATPase activity
(9). The ensuing rapid closure of the peptide binding pocket would trap
the substrate within the closed pocket of the ADP form of the Hsp70
molecule. The J-domain would thus stimulate peptide binding by Hsp70s
(10, 11). Release of the bound Hsp70 molecule from the peptide
substrate would occur when exchange of ADP for ATP re-opens the peptide binding pocket (11). Under equilibrium conditions, an isolated Hsp70
has a preference for peptide sequences of at least seven mostly
hydrophobic amino acids (12-14). Activation by the J-domain causes a
steady-state situation which allows an Hsp70 to bind even polar
peptides (11).
Two models have been proposed for how the J-domain interacts with an
Hsp70. In one model, the ATP form of the Hsp70 would bind to the
J-domain, the nucleotide would be hydrolyzed, and the Hsp70 would be
stably bound in its ADP form to the J-domain. This would represent an
activated form of the Hsp70 which could subsequently be transferred to
a peptide substrate (15-17). This mechanism is supported by
experiments in which eukaryotic Hsp70s were found to be bound in their
ADP form to fusion proteins of a J-domain to glutathione
S-transferase
(GST-J)1 (16, 17). However,
it was not demonstrated that the GST-J·Hsp70·ADP complex
represented a precursor for the Hsp70-peptide substrate interaction. In
an alternative model, the interaction of the Hsp70 with the J-domain
would be extremely transient, even in the absence of a peptide
substrate (see Ref. 4, and references therein). In the presence of
a substrate, the Hsp70 would immediately be transferred from the
J-domain to the peptide, resulting in a stable peptide·Hsp70·ADP
complex. This view is supported by experiments involving DnaK, the
bacterial Hsp70, and its J-partner DnaJ (10). It is possible that the
different results reflect fundamental differences between the
eukaryotic and prokaryotic Hsp70 systems.
A well studied system in which an Hsp70 family member plays an
essential role is the post-translational transport of proteins across
the membrane of the yeast endoplasmic reticulum (for review, see Refs.
18 and 19). The lumenal Hsp70 family member BiP (Kar2p) is required to
transport proteins through a channel in the endoplasmic reticulum
membrane formed by the Sec complex (20-23). The J-partner for BiP is a
lumenal domain of the Sec63p component of the Sec complex (15, 17, 24,
25). Upon interaction with the J-domain of Sec63p, BiP binds to the
translocation substrate and prevents its backwards movement through the
channel, thus acting as a molecular
ratchet.2 Whether BiP also
actively "pulls" on the substrate is unclear (26).
In the present study, we have investigated the binding of yeast BiP to
GST-J and to the Sec complex. We demonstrate that, in the absence of
added peptides, BiP binds to GST-J as if it was a peptide
substrate. BiP appears to interact with the J-domain only very
transiently, but this brief interaction is sufficient to induce
nucleotide hydrolysis and activate BiP for peptide binding. Thus, BiP
does not "wait" for the substrate while bound to the J-domain. Our
data indicate that the transient nature of the Hsp70-J interaction is
conserved between eukaryotes and prokaryotes.
Cloning and Purification of GST-J--
DNA encoding the J-domain
of SEC63 was amplified by polymerase chain reaction using 5'-primer,
CGCGGGGATCCCCACAAAATTATTTGATCCTTATG, and 3'-primer,
CGCGGAATTCCCGTGATGGTGATGGTGATGGTGTGGATGACCGTATTTCAAAT. The product was
cloned into pGEX-3x (Pharmacia). The GST-J fusion protein was purified
essentially as described in Ref. 17, using its affinity to a GSH column
(Pharmacia) and a Ni-NTA column (Qiagen), extensively dialyzed against
buffer A (150 mM KCl, 50 mM Hepes, pH 7.0, 5 mM MgCl2), and frozen in aliquots.
Purification of BiP and BiP Mutants--
The plasmid pMR2606
encoding wild type BiP was a kind gift from Mark Rose. The plasmids
encoding BiP mutants T249G, G247D, and T59G have been described (27,
28). Plasmids encoding the BiP peptide binding mutants G488D, G445D,
V519R, and T448R were made with the P-Alter system (Promega). The
proteins were purified as described (22) and gel filtered with a PD10
column (Pharmacia) equilibrated in buffer A. All protein concentrations
were determined, using the method described in Ref. 29.
SPR Experiments--
Experiments were done on a BIAcore upgrade
machine, using CM5 research grade chips (BIAcore) at 25 °C. Buffer A
was used as the running buffer at a flow rate of 5-7 µl/min. GST-J
was immobilized in a sodium acetate buffer, pH 4-5, via
NH2-specific cross-linking following the instructions of
the manufacturer (BIAcore). The chip was first activated using EDC and
N-hydroxysuccinimide, followed by the immobilization of
GST-J and quenching of excess reagent with ethanolamine. If not
otherwise indicated, the chip was first equilibrated with buffer A
containing 1 µg/ml leupeptin, 0.5 µg/ml chymostatin, 0.25 µg/ml
elastatinal, and 0.1 µg/ml pepstatin A as protease inhibitors and 2 mM nucleotide, followed by the injection of BiP in an
otherwise identical buffer. The chip was regenerated by a brief
injection of 1% Triton and 1 mM ATP in buffer A. The chip
did not loose more then 10% of its BiP binding activity after 12 rounds of BiP injections.
For the dissociation experiments, BiP in buffer A including 2 mM ATP and protease inhibitors was injected first, followed by injection of 2 mM nucleotide, with or without 2 mM peptide P5 in an otherwise identical buffer lacking BiP.
For the peptide inhibition studies, the chip was equilibrated as
described, in the presence of peptide followed by the injection of BiP
in an otherwise identical buffer. Peptide binding studies were done as
described previously (11). The chip was first equilibrated in buffer
with nucleotide and protease inhibitors as described above with or
without GST-J, followed by injection of BiP in an otherwise identical buffer.
Binding of BiP to the Sec Complex--
The Sec complex was
purified as described previously (22) from a wild type or a
sec63-1 strain. For experiments with the Sec complex,
streptavidin chips (BIAcore) were used with buffer B (150 mM KCl, 50 mM Hepes, pH 7.0, 5 mM
MgCl2, 1 mM MnCl2, 5 mM
CaCl2, 7 mM ATPase Experiments--
BiP (32 µM) was incubated
either with or without peptide P5 at 1 mM and the indicated
concentration of J-GST in buffer A at room temperature in a final
volume of 20 µl. The reactions were started by adding a mixture of 4 mM ATP and [ Release of pp BiP Binds to GST-J--
In previous experiments stable
interactions between Hsp70 family members and fusion proteins of their
J-protein partners with GST were observed (16, 17), but the nature of
these complexes remained unclear. To further investigate this
interaction, we used recombinant BiP and a fusion of the J-domain of
Sec63p with GST (GST-J) in a surface plasmon resonance (SPR) assay
(30). In an SPR assay, one component is immobilized on a surface, and the interaction partner is in a solution which is passed over it.
Binding between the two increases the refractive index at the surface.
The signal (given in response units, RU) is directly proportional to
the mass of protein bound to the surface. This assay makes it possible
to follow the association and dissociation of proteins in real time.
GST-J was immobilized via NH2-specific cross-linking and
binding of BiP was tested in the presence of ATP or ADP. In ATP, BiP
was bound with fast kinetics, while in ADP the response was as low as
in the absence of GST-J (Fig.
1A, see also Ref. 17). In
agreement with previous results (17), the GST-J·BiP complex could
also be isolated with GSH beads (data not shown). Previous experiments
have demonstrated that BiP binds neither to GST alone nor to a GST-J
molecule containing the sec63-1 point mutation in its J-domain
(17).
To determine the apparent affinity of BiP for GST-J, we measured the
time course of binding for different BiP concentrations in the presence
of ATP. The dependence of the plateau values on the BiP concentration
could not be fitted with a single binding constant; the half-maximum
concentration was approximately 5 µM (Fig.
1B). In the presence of ADP only negligible binding of BiP to GST-J was observed. Since the signal of the SPR assay is directly proportional to the mass of protein on the surface, we were able to
determine the stoichiometry of the GST-J·BiP complex. Taking into
account the different molecular weights of BiP and GST-J, we estimate
that at the highest BiP concentration an average of approximately two
BiP molecules are bound to each GST-J molecule.
Binding of BiP to GST-J Requires ATP Hydrolysis--
Since the
binding of BiP to GST-J is strictly dependent on ATP, the ATP-bound
form of BiP is likely to make the initial interaction with the
J-domain. To determine whether ATP hydrolysis is required for the
binding of BiP to GST-J, we employed BiP mutants with single amino acid
changes in their ATPase domain (27, 28). The mutants are trapped at
different stages of the ATPase cycle. BiP G247D is unable to bind ATP,
BiP T59G binds ATP, but is unable to undergo a conformational change
following ATP binding, and BiP T249G binds ATP and undergoes the
conformational change, but fails to hydrolyze the bound nucleotide
(Ref. 27, and data not shown). As shown in Fig.
2, none of these mutants interacted with GST-J, demonstrating that ATP hydrolysis is required. Previous experiments with nonhydrolyzable analogs of ATP led to the same conclusion (17), but protease protection and peptide binding experiments indicate that, in contrast to the mutation T249G, the
analogs do not induce the genuine ATP conformation of BiP (data not
shown). ATP hydrolysis during binding of GST-J is also supported by
pull-down experiments with GSH beads which demonstrated that the
nucleotide bound to GST-J-BiP is ADP (data not shown, see also Refs. 16
and 17).
Effects of a Hydrophobic Peptide--
We next tested whether the
GST-J·BiP complex was an activated precursor for BiP's interaction
with peptides as has been suggested (16, 17) or whether it represented
a subsequent state with GST-J bound to the peptide binding pocket of
BiP. To distinguish between these two models we investigated the
effects of the hydrophobic peptide P5 (ALLLSAPRR; Ref. 31). This
peptide binds BiP well in ADP (Kd about 20 µM), but much more weakly in ATP (11). We first tested
whether the pre-binding of P5 would inhibit BiP's interaction with
GST-J. As shown in Fig. 3A,
peptide P5 in solution competed with immobilized GST-J for BiP binding.
At the highest peptide concentration used, binding of BiP was reduced to approximately 15% of the original value. We estimate an inhibition constant of approximately 500 µM for the peptide.
To investigate the effect of peptide on the dissociation of BiP from
GST-J, BiP was prebound to GST-J with or without ATP, and its
dissociation was followed in ATP or ADP in the absence or presence of 2 mM peptide P5 (Fig. 3B). The dissociation in ADP
was relatively slow (estimated half-life approximately 100 s, see
also Ref. 16) and biphasic, probably due to the different dissociation
rates of the multiple BiP molecules bound to GST-J. The peptide had no
effect on the dissociation rate. In ATP the release of BiP was
significantly faster (half-life approximately 12 s), and the
peptide had a small effect, most likely by preventing the re-binding of
dissociated BiP to GST-J. The inhibitory effect of the peptide on the
formation of the GST-J·BiP complex (Fig. 3A) is therefore
not due to an increased off-rate of BiP. In addition, the dissociation
kinetics of BiP from GST-J in ADP and ATP are very similar to those for
the dissociation of BiP from a synthetic peptide (11). These data
therefore suggest that GST-J is bound to BiP as a peptide substrate,
arguing that the complex represents the final BiP-substrate
interaction, rather than a precursor to it.
GST-J and Peptide P5 Stimulate BiP's ATPase Activity--
To
exclude the possibility that the peptide prevents BiP from interacting
with the J-domain, we tested whether GST-J could stimulate the ATPase
activity of BiP in the presence of peptide. BiP's ATPase activity was
followed with or without peptide P5 and GST-J, allowing each BiP
molecule to hydrolyze many molecules of ATP (Fig. 3C). BiP
alone hydrolyzed ATP at a rate of approximately 0.1 mol/mol/min. GST-J
stimulated this basal rate approximately 5-fold (see also Ref. 17) with
maximal stimulation reached at stoichiometric amounts of GST-J relative
to BiP. In the absence of GST-J, peptide P5 stimulated BiP's ATPase
activity approximately 2-fold. Addition of GST-J resulted in further
stimulation. At saturating amounts of GST-J, BiP's ATPase activity
with and without peptide was indistinguishable. We conclude that even
though the peptide inhibited the stable binding of BiP to GST-J (Fig.
3A), it did not prevent a transient interaction which led to
the stimulation of BiP's ATPase activity. These data are consistent
with the view that the J-domain of GST-J activates BiP to bind GST-J as
a peptide substrate.
Effect of GST-J on BiP's Peptide Binding Activity--
If BiP
binds GST-J as a peptide substrate, its peptide binding pocket should
be occupied in the GST-J·BiP complex and unable to bind other
peptides. To test this prediction, we investigated the binding of BiP
to the hydrophobic peptide P5, immobilized via a 6-amino acid spacer,
in the absence or presence of GST-J. As reported before, BiP binds to
the peptide more strongly in ADP than in ATP (Fig. 3D, solid
curves; Ref. 11). The on- and off- rates are relatively slow in
ADP and significantly faster in ATP, consistent with closed and open
peptide binding pockets of BiP, respectively (7, 11). Next, we mixed
GST-J in solution with BiP and ATP before passing the mixture over the
peptide surface. As discussed above, GST-J rapidly stimulates the
ATPase activity of BiP, thereby converting BiP-ATP into
GST-J·BiP·ADP. However, when compared with BiP-ADP, the binding was
drastically reduced (Fig. 3D, broken curves). Thus, the
complex of GST-J·BiP·ADP cannot interact with the peptide because
BiP's peptide binding pocket is already occupied. We conclude that
this complex is not an activated precursor for subsequent peptide
binding but, to the contrary, prevents such an interaction.
BiP Mutants Defective in Peptide Binding--
We next tested
whether BiP's peptide binding activity is required for the formation
of the GST-J·BiP complex. Point mutations were introduced into BiP's
peptide binding pocket to render it nonfunctional. The mutations G445D
and G488D were chosen because analogous mutations were found in a
genetic screen for mutations in the peptide-binding domain of DnaK in
Escherichia coli (32). The mutations V519R and T448R should
fill the binding pocket with a bulky residue (5), and therefore might
inhibit peptide binding. Indeed, none of these BiP mutants was able to
bind the hydrophobic peptide P5 (Fig.
4A). They were, however, able
to hydrolyze ATP efficiently (data not shown) and were thus clearly
different from the three ATPase mutants described above, which can bind
peptides (data not shown), but fail to hydrolyze ATP. None of the
peptide-binding mutants was able to bind GST-J (Fig. 4B). A
similar mutant in DnaK was also unable to bind to DnaJ (33).
Furthermore, a truncation mutant of BiP containing only the ATPase
domain was unable to bind GST-J (data not shown). On the other hand, a
mutant lacking the COOH-terminal lid domain but maintaining the ATPase
and peptide-binding domains was still able to bind GST-J (data not
shown, see also Refs. 11, 34, and 35). Taken together, BiP's peptide
binding activity appears to be required for the generation of a stable GST-J·BiP complex.
All peptide binding mutants were tested for their ability to move the
translocation substrate pre-pro- Binding of BiP to the Sec Complex--
Based on the experiments
with GST-J, we reasoned that, in the absence of a translocation
substrate, BiP might bind to the Sec complex itself. In fact, in
previous experiments stable complexes of BiP with the J-protein Sec63p
could be isolated from yeast microsomal membranes (15).
We immobilized the soluble, purified Sec complex via an antibody
against the Sec62p component. BiP was passed over it in a detergent-containing buffer with either ATP or ADP. As with GST-J, the
binding of BiP to the Sec complex was significantly stronger in ATP
than in ADP (Fig. 5, solid
curves). The lower level of binding in ADP is probably due to the
presence of hydrophobic domains of the Sec complex. Binding was
specific for the Sec complex since in its absence only the residual
response due to changes caused by the presence of BiP in solution was
observed (Fig. 5, lower dashed curves).
To further test the specificity of the interaction, we used the Sec
complex purified from the sec63-1 mutant, containing a point
mutation in the J-domain of Sec63p (36) which makes it defective in
translocation (37). This protein was inactive since binding of BiP in
the presence of ATP was identical to that in the presence of ADP (Fig.
5, upper dashed curves, see also Ref. 15).
ATP-dependent binding was also observed with a subcomplex of the Sec complex (38), containing Sec62p, Sec63p, Sec71p, and Sec72p
(data not shown). Taken together, these data indicate that the J-domain
of Sec63p can activate BiP to bind to the Sec complex in a manner that
is analogous to the interaction observed with the GST-J fusion protein.
Our experiments discriminate between two models proposed for the
interaction of an Hsp70 molecule with its J-protein partner. Our data
are inconsistent with a model in which, in the absence of a substrate,
Hsp70 forms an activated, stable J·Hsp70·ADP complex, from which
the bound Hsp70 is subsequently transferred to a peptide (15-17).
Rather, they suggest that Hsp70 interacts only very transiently with
the J-domain and is immediately transferred to a peptide substrate, be
it the natural substrate or the J-protein itself (4, 10). Although we
confirm the generation of a stable J-protein·Hsp70·ADP complex in
an ATP-dependent reaction, we demonstrate that the Hsp70 is
bound to the J-protein as if it were a peptide substrate. The complex
therefore represents the final, rather than an intermediate, state of
the peptide binding reaction.
The following observations support our conclusion. 1) A hydrophobic
peptide in solution competes with GST-J for the formation of the
GST-J·BiP·ADP complex. The peptide does not accelerate the
dissociation of BiP from GST-J, nor does it prevent the interaction of
GST-J with BiP that is required for ATPase stimulation. We therefore
conclude that the peptide exerts its inhibitory effect by occupying the
same peptide-binding domain to which GST-J is ultimately bound. In
addition, in agreement with other results (4, 10, 33, 35, 39), these
data show that peptide and J-domain interact with BiP at different
sites. 2) Since the GST-J·BiP·ADP complex binds a hydrophobic
peptide much more weakly than BiP·ADP, GST-J must block BiP's
peptide binding pocket. 3) The fact that two BiP molecules are bound
per GST-J molecule and the biphasic dissociation kinetics argue against
the existence of a stable, defined J-domain-BiP interaction. Rather,
these data indicate that BiP molecules are bound to at least two
distinct regions of GST-J. 4) The kinetics of dissociation of BiP from
GST-J resembles that of BiP from peptide substrates. In both cases
dissociation is fast in ATP and slow in ADP, as expected from open and
closed peptide binding pockets, respectively (7, 11). 5) Binding of BiP
to peptide when co-immobilized with the J-domain (11) is strikingly
similar to BiP's interaction with immobilized GST-J. The kinetics of
association and dissociation are very similar, ATP hydrolysis is
required for the binding reaction, and the final complex contains ADP.
We therefore conclude that formation of the GST-J·BiP·ADP complex
involves the activation of BiP by the J-domain. 6) BiP mutants whose
peptide binding activity is altered by point mutations or deletions
fail to bind GST-J. 7) Similarly to the results with GST-J, BiP can be
transferred in a J-domain- and ATP-dependent manner to the
Sec complex itself. Limited availability of the purified Sec complex
and its dissociation from the surface during subsequent SPR experiments
have made it impossible to demonstrate directly that the peptide
binding pocket of BiP is involved in this interaction. However, the
analogy between GST-J and the Sec complex strongly suggests that BiP
binds both in an identical manner.
Our results suggest that a J-domain·BiP·ATP complex, which is too
short-lived to be detected in conventional binding experiments, is
transiently formed. The short half-life is caused by the J-protein inducing rapid ATP hydrolysis by BiP. Upon ATP hydrolysis, BiP binds to
peptides in close proximity to the J-domain (11). The final complex
contains BiP, ADP, and peptide, but lacks the J-domain. BiP is rather
promiscuous following J-activation and can therefore bind to
essentially any substrate (11), including polypeptide parts of the
J-protein itself. The peptide motifs in the J-proteins to which BiP is
bound are unknown, but they are probably outside the J-domain.
Our data argue against a previously proposed model in which BiP in its
ADP form would wait for the translocation substrate while bound to the
J-domain at the lumenal end of the channel (15). Although we have
confirmed that BiP associates with the Sec complex or the Sec62/63p
subcomplex in a J- and ATP-dependent manner, this complex
is likely not a precursor for peptide interaction. Rather, in the
absence of a translocation substrate, BiP appears to bind to
polypeptide segments of the Sec complex, as observed with the GST-J protein.
During translocation, the translocating polypeptide would emerge from
the channel close to the J-domain of Sec63p and J-activated BiP would
be transferred to the substrate. Once bound, BiP would prevent
backwards movements of the polypeptide chain, thus acting as a
molecular ratchet.2 BiP was also proposed to pull on the
translocation substrate (26). However, this would require a
conformational change of BiP while bound simultaneously to the J-domain
and the polypeptide substrate, which seems unlikely given the transient
nature of the BiP-J interaction. Simultaneous binding is also rendered
unlikely by our finding that more than one BiP molecule could bind to
GST-J. Moreover, since the addition of peptide does not stimulate the dissociation of BiP from its complex with GST-J, a complex containing BiP, J-domain, and translocation substrate would be stable, preventing any movement of the polypeptide chain.
J-activated binding of BiP to polypeptide segments of the Sec complex
in the absence of a translocation substrate may have physiological
significance. Mammalian BiP was proposed to seal the lumenal end of the
channel to small ions (40). In an analogous manner, BiP may serve to
seal the channel in the post-translational pathway. J-activated BiP
would continuously associate with and dissociate from the Sec complex,
providing a dynamic lid for the channel, and would switch to binding of
a translocation substrate as soon as it emerges from the lumenal end of
the channel. "Futile" ATP hydrolysis would not be excessively high
because the steady state ATPase activity is only stimulated 5-fold by
the J-protein. On the other hand, it is possible that the J-domain is
only exposed for BiP interaction once a translocation substrate is
bound to the channel.
Our results may also have relevance for studies on the import of
proteins into mitochondria (26, 41-44). There, a stable complex of
mitochondrial Hsp70 with its partner protein of the inner membrane,
Tim44p, is formed following ATP hydrolysis (45). In light of our
results, it appears questionable whether it represents a precursor for
substrate binding.
A dimeric complex between Hsp70 and peptide appears to be the general
end product in many Hsp70 systems, such as the auxilin-Hsc70 system
responsible for the uncoating of clathrin-coated vesicles (16, 46). Our
data indicate that such complexes only form efficiently in the presence
of a J-domain, despite the presence of high concentrations of Hsp70s in
the cell. Previously it has been observed that in the presence of ATP
the yeast J-protein Ydj1p releases an unfolded protein from the
cytosolic Hsp70 homolog Ssa1p (47). In light of our data it seems
possible that, under these conditions, Ydj1p competes with the unfolded
protein for binding of activated Ssa1p, thus apparently stimulating
peptide dissociation.
In the bacterial system a transient interaction between DnaK and the
J-domain of DnaJ has been demonstrated (4, 10, 48). The J-domain alone
did not stimulate the ATPase activity of DnaK, in contrast to either
the J-domain plus a following domain (G/F-domain) (49), the full-length
DnaJ, or the J-domain plus a separately added hydrophobic peptide (10).
It is therefore possible that with the longer J-protein constructs DnaK
is targeted to segments COOH-terminal of the J-domain (10). The
ATP-dependent formation of a complex between DnaK and DnaJ
(33, 35, 50) is thus likely to be similar to that between GST-J and
BiP, with a peptide segment occupying the peptide-binding domain of the
Hsp70. Recently, the binding site for the J-domain has been mapped to a
region in the ATPase domain of DnaK (33, 35). In addition, using NMR a
nucleotide-independent interaction between the J-domain of DnaJ and the
ATPase domain of DnaK was found (39), presumably reflecting the
transient interaction that escapes detection in other experiments.
Taken together, it appears that the interaction between a J-domain and
Hsp70 is highly conserved in evolution.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol, 0.5%
digitonin (Merck)). The Sec complex was immobilized by first injecting
saturating amounts of biotinylated protein A, followed by a polyclonal
antibody raised against a peptide epitope at the cytosolic part of
Sec62p, and finally the Sec complex. By this procedure, approximately
1200 RU Sec complex could be immobilized. For the injection of BiP, the
chip was first equilibrated in a buffer identical to buffer B, except
instead of digitonin the detergent Deoxy-Big-Chap (Calbiochem) was used
in the presence of 1 mM ADP or ATP, followed by an
injection of BiP in an otherwise identical buffer. BiP also bound
specifically to the Sec complex in the presence of the detergent
digitonin (data not shown), although somewhat more weakly, most likely
because the larger micelles of the detergent digitonin are able to
shield parts of the J-domain of Sec63p.
-32P]ATP and incubated for 120 min. At different time points, samples were taken and applied to
polyethyleneimide-cellulose. The cellulose sheets were developed by
thin layer chromatography in a 0.5 M LiCl, 0.5 M formic acid buffer, and analyzed using a Fujix
PhosphorImager. If not otherwise indicated, chemicals were purchased
from Sigma.
F from the Sec Complex--
Experiments were
done exactly as described previously. (28).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Binding of BiP to GST-J. A,
1000 RU of GST-J were immobilized. At time 0, a solution containing 10 µM BiP and either 2 mM ADP or ATP was
introduced (arrow, "BiP").
"Buffer" indicates the point at which the BiP solution
was replaced with buffer alone (arrow). The dashed
curve gives the background binding of BiP with ATP but in the
absence of GST-J (background). B, 1200 RU of
GST-J were immobilized. Different concentrations of BiP were introduced
in the presence of either 2 mM ADP (circles) or
ATP (triangles). The response was followed with time and the
maximum values were plotted versus the BiP
concentration.

View larger version (12K):
[in a new window]
Fig. 2.
ATP hydrolysis mutants of BiP do not bind
GST-J. 600 RU of GST-J were immobilized. At time 0 a solution
containing 2 mM ATP and either 15 µM wild
type BiP (wt) or mutants carrying point mutations in their
ATPase domain were introduced. Mutant G247D is unable to bind
nucleotide, T59G is unable to undergo a conformational change after ATP
binding, and T249G fails to hydrolyze the bound ATP.

View larger version (20K):
[in a new window]
Fig. 3.
Influence of a hydrophobic peptide on BiP's
interaction with GST-J. A, 1200 RU of GST-J were
immobilized. A solution containing both 2 mM ATP and the
indicated concentrations of peptide P5 was introduced, and at time 0 10 µM BiP was added. B, 600 RU of GST-J were
immobilized. BiP was pre-bound to GST-J in the presence of ATP.
Dissociation was followed in the presence of 2 mM ADP or
ATP, without (solid curves) or with (dashed
curves) 2 mM peptide P5. C, a steady state
ATPase experiment was performed by incubating 32 µM BiP
with different concentrations of GST-J, either without
(circles) or with (triangles) 1 mM
peptide P5. The reactions were started by adding a mixture of
[
-32P]ATP and ATP to a final concentration of 4 mM. At the indicated time points the amount of hydrolyzed
nucleotide was determined by thin layer chromatography. The hydrolysis
rate is plotted versus the molar ratio GST-J:BiP.
D, 1300 RU of peptide P5 were immobilized using a 6-amino
acid spacer. A buffer containing either 2 mM ADP or ATP
(solid curves) or 2 mM ATP and the indicated
concentrations of GST-J (dashed curves) was introduced and,
at time 0, 10 µM BiP was added.

View larger version (17K):
[in a new window]
Fig. 4.
Mutants defective in peptide binding.
A, 1000 RU of peptide P5 were immobilized using a 6-amino
acid spacer. A buffer containing 2 mM ADP was introduced
and, at time 0, 20 µM wild type BiP (wt) or
BiP mutants carrying point mutations in their peptide-binding domain
were added. B, as in A, except that 1300 RU of
GST-J were immobilized and binding was tested in the presence of 2 mM ATP. C, a soluble complex between
radiolabeled pp
F and the Sec complex was generated and incubated
with increasing concentrations of either wild type (wt,
squares) BiP or of BiP mutants containing a defective peptide
binding pocket: BiP G445D (diamonds), BiP V519R
(triangles), BiP T448R (circles), or BiP G488D
(crosses), respectively. The Sec complex was
immunoprecipitated with antibodies to Sec62p and the amount of
co-precipitated pp
F determined. The data are normalized to the
amount of pp
F bound to the Sec complex in the absence of added
BiP.
-factor (pp
F) through the channel
formed by the Sec complex (28). While wild type BiP releases pp
F
from the preformed complex of pp
F and Sec complex, the
peptide-binding mutants were much less active (Fig. 4C).
Previous experiments had demonstrated that the release reaction
reflects transport of pp
F through the channel (28). We conclude that BiP's peptide binding activity is required for protein transport into
the endoplasmic reticulum. In testing a large number of mutants, we
have found a perfect correlation between the decrease in BiP binding to
GST-J and defects in BiP's activity in a translocation assay. In
addition, our data indicate that the functions of both the ATPase and
peptide-binding domain are required for J-activated peptide binding.

View larger version (17K):
[in a new window]
Fig. 5.
BiP binds to the Sec complex. The Sec
complex was immobilized via its affinity to an anti-Sec62p antibody. At
time 0 30 µM BiP was added to the buffer containing
either 1 mM ADP or ATP, which was passing continuously over
the surface. At the time point where the curves begin to fall, the BiP
solution was replaced by buffer. Controls were performed in the absence
of Sec complex (lower dashed curves) or with the Sec complex
from the sec63-1 mutant, carrying a point mutation in the
J-domain (upper dashed curves).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank T. Kirchhausen and W. Boll for invaluable assistance with the SPR experiments, P. Silver, S. Harrison, T. Ellenberger, T. Kirchhausen, B. Bukau, T. Laufen, S. Ruediger, and members of the laboratory for stimulating discussions, P. Christen, M. Rose, and P. Silver for materials, and Will Prinz for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* The work was supported in part by National Institutes of Health Grant GM54238-02.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Howard Hughes Medical Institute Investigator. To whom
correspondence should be sent: Howard Hughes Medical Institute and
Department of Cell Biology, Harvard Medical School, 240 Longwood Ave.,
Boston, MA 02115. Tel.: 617-432-0637; Fax: 617-432-1190; E-mail:
tom_rapoport@hms.harvard.edu.
2 Matlack, K. E. S., Misselwitz, B., Plath, K., and Rapoport, T. A. (1999) Cell 97, 553-564
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
GST, glutathione
S-transferase;
GST-J, fusion protein containing the
J-domain and GST;
GSH, glutathione;
SPR, surface plasmon resonance;
RU, response units;
pp
F, pre-pro-
-factor;
EDC, N-ethyl-N'-(3-dimethylaminopropyl)-carbodiimide
hydrochloride.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Georgopoulos, C. (1992) Trends Biochem. Sci. 17, 295-299[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Gething, M.-J., and Sambrook, J. (1992) Nature 355, 33-45[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Hartl, F. U. (1996) Nature 381, 571-580[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Zhu, X., Zhao, X., Burkholder, W. F., Gragerov, A., Ogata, C. M., Gottesman, M. E., and Hendrickson, W. (1996) Science 272, 1606-1614[Abstract] |
| 6. | Palleros, D. R., Reid, K. L., Shi, L., Welch, W. J., and Fink, A. L. (1993) Nature 365, 664-666[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Schmid, D.,
Baici, A.,
Gehring, H.,
and Christen, P.
(1994)
Science
263,
971-973 |
| 8. | Kelley, W. L. (1998) Trends Biochem. Sci. 23, 222-227[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Liberek, K.,
Marszalek, J.,
Ang, D.,
Georgopoulos, C.,
and Zylicz, M.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2874-2878 |
| 10. |
Karzai, A. W.,
and McMacken, R.
(1996)
J. Biol. Chem.
271,
11236-11246 |
| 11. | Misselwitz, B., Staeck, O., and Rapoport, T. A. (1998) Mol. Cell 2, 593-603[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. (1991) Nature 353, 726-730[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Blond-Elguindi, S., Cwiria, S. E., Dower, W. J., Lipshutz, R. J., Sprang, S. R., and Sambrook, J. F. (1993) Cell 75, 717-728[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Ruediger, S., Germeroth, L., Schneider-Mergener, J., and Bukau, B. (1997) EMBO J. 16, 1501-1507[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Brodsky, J. L.,
and Schekman, R.
(1993)
J. Cell Biol.
123,
1355-1363 |
| 16. |
Holstein, S. E. H.,
Ungewickell, H.,
and Ungewickell, E.
(1996)
J. Cell Biol.
135,
925-937 |
| 17. | Corsi, A. K., and Schekman, R. (1997) J. Cell Biol. 173, 1483-1493 |
| 18. |
Corsi, A. K.,
and Schekman, R.
(1996)
J. Biol. Chem.
271,
30299-30302 |
| 19. | Matlack, K. E. S., Mothes, W., and Rapoport, T. A. (1998) Cell 92, 381-390[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Vogel, J. P.,
Misra, L. M.,
and Rose, M. D.
(1990)
J. Cell Biol.
110,
1885-1895 |
| 21. | Deshaies, R. J., Sanders, S. L., Feldheim, D. A., and Schekman, R. (1991) Nature 349, 806-808[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Panzner, S., Dreier, L., Hartmann, E., Kostka, S., and Rapoport, T. A. (1995) Cell 81, 561-570[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Hanein, D., Matlack, K. E. S., Jungnickel, B., Plath, K., Kalies, K.-U., Miller, K. R., Rapoport, T. A., and Akay, C. W. (1996) Cell 87, 721-732[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Sadler, I.,
Chiang, A.,
Kurihara, T.,
Rothblatt, J.,
Way, J.,
and Silver, P.
(1989)
J. Cell Biol.
109,
2665-2675 |
| 25. | Scidmore, M. A., Okamura, H. H., and Rose, M. D. (1993) Mol. Biol. Cell 4, 1145-1159[Abstract] |
| 26. | Glick, B. S. (1995) Cell 80, 11-14[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Wei, J.,
Gaut, J. R.,
and Hendershot, L. M.
(1995)
J. Biol. Chem.
270,
26677-26682 |
| 28. |
Matlack, K. E. S.,
Plath, K.,
Misselwitz, B.,
and Rapoport, T. A.
(1997)
Science
277,
938-941 |
| 29. | Edelhoch, H. (1967) Biochemistry 6, 1948-1954[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Fagerstam, L. G., Frostell, A., Karlsson, R., Kullman, M., Larsson, A., Malmqvist, M., and Butt, H. (1990) J. Mol. Recognit. 3, 208-214[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Pierpaoli, E. V.,
Sandmeier, E.,
Schonfeld, H. J.,
and Christen, P.
(1998)
J. Biol. Chem.
273,
6643-6649 |
| 32. |
Burkholder, W. F.,
Zhao, X.,
Zhu, X.,
Hendrickson, W. A.,
Gragerov, A.,
and Gottesman, M. E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10632-10637 |
| 33. |
Suh, W. C.,
Burkholder, W. F.,
Lu, C. Z.,
Zhao, X.,
Gottesman, M. E.,
and Gross, C. A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
95,
15223-15228 |
| 34. |
Ungewickell, E.,
Ungewickell, H.,
and Holstein, S. E.
(1997)
J. Biol. Chem.
272,
19594-19600 |
| 35. |
Gaessler, C. S.,
Buchberger, A.,
Laufen, T.,
Mayer, M. P.,
Schroeder, H.,
Valencia, A.,
and Bukau, B.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
95,
15229-15234 |
| 36. | Nelson, K. M., Kurihara, T., and Silver, P. A. (1993) Genetics 134, 159-173[Abstract] |
| 37. |
Rothblatt, J. A.,
Deshaies, R. J.,
Sanders, S. L.,
Daum, G.,
and Schekman, R.
(1989)
J. Cell Biol.
109,
2641-2652 |
| 38. | Panzner, S., Dreier, L., Hartmann, E., Kostka, S., and Rapoport, T. A. (1995) Cell 81, 561-570 |
| 39. |
Greene, M. K.,
Maskos, K.,
and Landry, S. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6108-6113 |
| 40. | Hamman, B. D., Hendershot, L. M., and Johnson, A. E. (1998) Cell 92, 747-758[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Schneider, H. C., Berthold, J., Bauer, M. F., Dietmeier, K., Guiard, B., Brunner, M., and Neupert, W. (1994) Nature 371, 768-774[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Rassow, J.,
Maarse, A. C.,
Krainer, E.,
Kubrich, M.,
Muller, H.,
Meijer, M.,
Craig, E. A.,
and Pfanner, N.
(1994)
J. Cell Biol.
127,
1547-1556 |
| 43. | Horst, M., Azem, A., Schatz, G., and Glick, B. S. (1997) Biochim. Biophys. Acta 1318, 71-78[Medline] [Order article via Infotrieve] |
| 44. | Neupert, W. (1997) Annu. Rev. Biochem. 66, 863-917[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Schneider, H.-C., Westermann, B., Neupert, W., and Brunner, M. (1996) EMBO J. 15, 5796-5803[Medline] [Order article via Infotrieve] |
| 46. | Ungewickell, E., Ungewickell, H., Holstein, S. E. H., Lindner, R., Prasad, K., Barouch, W., Martin, B., Greene, L. E., and Eisenberg, E. (1995) Nature 378, 632-635[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Cyr, D. M.,
Lu, X.,
and Douglas, M. G.
(1992)
J. Biol. Chem.
267,
20927-20931 |
| 48. |
Liberek, K.,
Wall, D.,
and Georgopoulos, C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6224-6228 |
| 49. |
Wall, D.,
Zylicz, M.,
and Georgopoulos, C.
(1994)
J. Biol. Chem.
269,
5446-5451 |
| 50. |
Wawrzynow, A.,
and Zylicz, M.
(1995)
J. Biol. Chem.
270,
19300-19306 |
This article has been cited by other articles:
![]() |
A. J. Jermy, M. Willer, E. Davis, B. M. Wilkinson, and C. J. Stirling The Brl Domain in Sec63p Is Required for Assembly of Functional Endoplasmic Reticulum Translocons J. Biol. Chem., March 24, 2006; 281(12): 7899 - 7906. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Alder, Y. Shen, J. L. Brodsky, L. M. Hendershot, and A. E. Johnson The molecular mechanisms underlying BiP-mediated gating of the Sec61 translocon of the endoplasmic reticulum J. Cell Biol., January 31, 2005; 168(3): 389 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Steel, D. M. Fullerton, J. R. Tyson, and C. J. Stirling Coordinated Activation of Hsp70 Chaperones Science, January 2, 2004; 303(5654): 98 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Cunnea, A. Miranda-Vizuete, G. Bertoli, T. Simmen, A. E. Damdimopoulos, S. Hermann, S. Leinonen, M. P. Huikko, J.-A. Gustafsson, R. Sitia, et al. ERdj5, an Endoplasmic Reticulum (ER)-resident Protein Containing DnaJ and Thioredoxin Domains, Is Expressed in Secretory Cells or following ER Stress J. Biol. Chem., January 3, 2003; 278(2): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gautschi, A. Mun, S. Ross, and S. Rospert A functional chaperone triad on the yeast ribosome PNAS, April 2, 2002; 99(7): 4209 - 4214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kabani, J.-M. Beckerich, and C. Gaillardin Sls1p Stimulates Sec63p-Mediated Activation of Kar2p in a Conformation-Dependent Manner in the Yeast Endoplasmic Reticulum Mol. Cell. Biol., September 15, 2000; 20(18): 6923 - 6934. [Abstract] [Full Text] |
||||
![]() |
J. Tyedmers, M. Lerner, C. Bies, J. Dudek, M. H. Skowronek, I. G. Haas, N. Heim, W. Nastainczyk, J. Volkmer, and R. Zimmermann Homologs of the yeast Sec complex subunits Sec62p and Sec63p are abundant proteins in dog pancreas microsomes PNAS, June 20, 2000; 97(13): 7214 - 7219. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ellgaard, M. Molinari, and A. Helenius Setting the Standards: Quality Control in the Secretory Pathway Science, December 3, 1999; 286(5446): 1882 - 1888. [Abstract] [Full Text] |
||||
![]() |
M. Chevalier, H. Rhee, E. C. Elguindi, and S. Y. Blond Interaction of Murine BiP/GRP78 with the DnaJ Homologue MTJ1 J. Biol. Chem., June 23, 2000; 275(26): 19620 - 19627. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Haigh and A. E. Johnson A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane J. Cell Biol., January 21, 2002; 156(2): 261 - 270. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||